Tenex Health, Inc.
Minimally invasive ultrasonic needle device for treating chronic tendon and bone spur pain
- Sector
- Medtech
- Headquarters
- ROCHESTER, MN
- Founded
- 2009
- Latest Form D
- $30M offered, Feb 2013
- Total capital
- $5.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5.9M
- 4 Form D · last Feb 2013
- 164 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 10
- 7 pending · first 2017
- Rank in peer group#202 of 1112
Capital timeline
Latest events
- Offering registeredForm D · SEC · 4th filing$30M
- Offering registeredForm D · SEC · 3rd filing$8M
- Private capital raisedForm D · SEC · 2nd filing$4.6M
- Private capital raisedForm D · SEC · 1st filing$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#202 · top 18%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Bernard Morrey, M.D.Executive OfficerNamed in SEC Form D filings
- Clay WilemonDirectorNamed in SEC Form D filings
- Darryl BarnesExecutive OfficerNamed in SEC Form D filings
- Ivan MijatovicDirectorNamed in SEC Form D filings
- Jagi GillExecutive Officer, DirectorNamed in SEC Form D filings
- Jay SmithExecutive OfficerNamed in SEC Form D filings
Show all 10 people
- Julie FlaneryExecutive OfficerNamed in SEC Form D filings
- Rom PapadopoulosExecutive Officer, DirectorNamed in SEC Form D filings
- Rom PapodopolousDirectorNamed in SEC Form D filings
- Tate ParhamExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 10 granted of 17- GrantedSubcutaneous Wound DebridementUSPTOUS 12,667,377
- PendingSystems And Methods For Tissue TreatmentUSPTOApplication 17813419
- GrantedSubcutaneous Wound DebridementUSPTOUS 11,457,937
Show all 17 patent records
- Subcutaneous Wound DebridementJun 30, 2026 · US 12,667,377Granted
- Systems And Methods For Tissue TreatmentNov 3, 2022 · Application 17813419Pending
- Subcutaneous Wound DebridementOct 4, 2022 · US 11,457,937Granted
- Systems And Methods For Tissue TreatmentAug 9, 2022 · US 11,406,415Granted
- Subcutaneous Wound DebridementJul 14, 2020 · US 10,709,461Granted
- Systems And Methods For Tissue TreatmentDec 31, 2019 · US 10,517,628Granted
- Subcutaneous Wound DebridementMay 8, 2018 · US 9,962,181Granted
- System and Method for Minimally Invasive Tissue Treatment Using Ultrasonic CannulaFeb 13, 2018 · US 9,888,937Granted
- Systems and Methods for Tissue TreatmentSep 26, 2017 · US 9,770,257Granted
- Elongated Needles for Ultrasonic ApplicationsSep 19, 2017 · US 9,763,689Granted
- Ultrasonic System and Method for Minimally Invasive Tissue TreatmentAug 15, 2017 · US 9,730,721Granted
- Laminated Needles and Methods of Making and Using SameApr 7, 2016 · Application 14505392Pending
- Systems And Methods For Tissue TreatmentApplication PCTUS2013044989Pending
- Subcutaneous Wound DebridementApplication PCTUS2015048075Pending
- System And Method For Minimally Invasive Tissue TreatmentApplication PCTUS2010062341Pending
- Laminated Needles And Methods For Making And Using SameApplication PCTUS2015053812Pending
- Elongated Needles For Ultrasonic ApplicationsApplication PCTUS2016032055Pending
Related companies, and why
- ReFlow Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Brainsway Ltd.Similar federal contract value in Medtech · null in contracts
- Fresenius Medical Care South Lewisville, LLCSimilar federal contract value in Medtech · null in contracts
- OssiFi IncSimilar federal contract value in Medtech · null in contracts
- Cytosorbents CorpSimilar federal contract value in Medtech · null in contracts
- Diagnos Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .